ADC is seen as a promising, next-generation anticancer drug, and SoluFlex Link was jointly developed by Lotte Biologics and Kanaph Therapeutics, a Korean bio-venture specializing in drug conjugation ...
SoluFlex Link is a proprietary ADC platform featuring a linker technology jointly developed by LOTTE BIOLOGICS and Kanaph Therapeutics, a biotech venture specializing in drug-conjugation technology.
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective Study
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2–Low, Hormone Receptor–Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback